Search research articles
Contact Us
Filters
Showing results (1-10 of 35) with videos related to
Page
of 4
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 26, 2025
Clinical Manifestations
Sophia Holzhauser, Oliver Goldhardt, Patrick Sommer, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
October 17, 2025
Elecsys CSF AD immunoassays: Sample stability for a new pre-analytical protocol for fresh CSF
Ekaterina Manuilova, Isabelle Schrurs, Sandra Rutz, et al.
Alzheimer'S Research & Therapy
|
April 27, 2022
Cerebrospinal fluid lactate levels along the Alzheimer's disease continuum and associations with blood-brain barrier integrity, age, cognition, and biomarkers
Paul Theo Zebhauser, Achim Berthele, Oliver Goldhardt, et al.
Alzheimer'S Research & Therapy
|
April 27, 2022
The cerebrospinal fluid biomarker ratio Aβ42/40 identifies amyloid positron emission tomography positivity better than Aβ42 alone in a heterogeneous memory clinic cohort
Michaela Amft, Marion Ortner, Udo Eichenlaub, et al.
Journal of Alzheimer'S Disease : JAD
|
July 12, 2021
Age-Dependency of Total Tau in the Cerebrospinal Fluid Is Corrected by Amyloid-β 1-40: A Correlational Study in Healthy Adults
Paul Theo Zebhauser, Achim Berthele, Marie-Sophie Franz, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
November 21, 2015
Visual Versus Fully Automated Analyses of 18F-FDG and Amyloid PET for Prediction of Dementia Due to Alzheimer Disease in Mild Cognitive Impairment
Timo Grimmer, Carolin Wutz, Panagiotis Alexopoulos, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration
|
June 23, 2020
Variability of clinical syndromes and cerebral glucose metabolism in symptomatic frontotemporal lobar degeneration associated with progranulin mutations
Abigail Licata, Timo Grimmer, Juliane Winkelmann, et al.
Journal of Proteomics
|
April 24, 2018
Brain-related proteins as potential CSF biomarkers of Alzheimer's disease: A targeted mass spectrometry approach
Ilijana Begcevic, Davor Brinc, Marshall Brown, et al.
Translational Neurodegeneration
|
August 31, 2019
Kallikrein-related peptidases 6 and 10 are elevated in cerebrospinal fluid of patients with Alzheimer's disease and associated with CSF-TAU and FDG-PET
Oliver Goldhardt, Inanna Warnhoff, Igor Yakushev, et al.
Neuro-Degenerative Diseases
|
July 3, 2019
Associations of Neprilysin Activity in CSF with Biomarkers for Alzheimer's Disease
Timo Grimmer, Oliver Goldhardt, Igor Yakushev, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 35) with videos related to
Sort By:
Page
of 4
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 26, 2025
Clinical Manifestations
Sophia Holzhauser, Oliver Goldhardt, Patrick Sommer, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
October 17, 2025
Elecsys CSF AD immunoassays: Sample stability for a new pre-analytical protocol for fresh CSF
Ekaterina Manuilova, Isabelle Schrurs, Sandra Rutz, et al.
Alzheimer'S Research & Therapy
|
April 27, 2022
Cerebrospinal fluid lactate levels along the Alzheimer's disease continuum and associations with blood-brain barrier integrity, age, cognition, and biomarkers
Paul Theo Zebhauser, Achim Berthele, Oliver Goldhardt, et al.
Alzheimer'S Research & Therapy
|
April 27, 2022
The cerebrospinal fluid biomarker ratio Aβ42/40 identifies amyloid positron emission tomography positivity better than Aβ42 alone in a heterogeneous memory clinic cohort
Michaela Amft, Marion Ortner, Udo Eichenlaub, et al.
Journal of Alzheimer'S Disease : JAD
|
July 12, 2021
Age-Dependency of Total Tau in the Cerebrospinal Fluid Is Corrected by Amyloid-β 1-40: A Correlational Study in Healthy Adults
Paul Theo Zebhauser, Achim Berthele, Marie-Sophie Franz, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
November 21, 2015
Visual Versus Fully Automated Analyses of 18F-FDG and Amyloid PET for Prediction of Dementia Due to Alzheimer Disease in Mild Cognitive Impairment
Timo Grimmer, Carolin Wutz, Panagiotis Alexopoulos, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration
|
June 23, 2020
Variability of clinical syndromes and cerebral glucose metabolism in symptomatic frontotemporal lobar degeneration associated with progranulin mutations
Abigail Licata, Timo Grimmer, Juliane Winkelmann, et al.
Journal of Proteomics
|
April 24, 2018
Brain-related proteins as potential CSF biomarkers of Alzheimer's disease: A targeted mass spectrometry approach
Ilijana Begcevic, Davor Brinc, Marshall Brown, et al.
Translational Neurodegeneration
|
August 31, 2019
Kallikrein-related peptidases 6 and 10 are elevated in cerebrospinal fluid of patients with Alzheimer's disease and associated with CSF-TAU and FDG-PET
Oliver Goldhardt, Inanna Warnhoff, Igor Yakushev, et al.
Neuro-Degenerative Diseases
|
July 3, 2019
Associations of Neprilysin Activity in CSF with Biomarkers for Alzheimer's Disease
Timo Grimmer, Oliver Goldhardt, Igor Yakushev, et al.
Page
of 4